Cargando…

The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review

The endogenous cannabinoid (eCB) system plays an important role in the pathophysiology of both psychotic disorders and substance use disorders (SUDs). The non-psychoactive cannabinoid compound, cannabidiol (CBD) is a highly promising tool in the treatment of both disorders. Here we review human clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batalla, Albert, Janssen, Hella, Gangadin, Shiral S., Bossong, Matthijs G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678854/ https://www.ncbi.nlm.nih.gov/pubmed/31330972 http://dx.doi.org/10.3390/jcm8071058

Ejemplares similares

The Impact of Cannabidiol on Human Brain Function: A Systematic Review
por: Batalla, Albert, et al.
Publicado: (2021)

Factors Moderating the Association between Cannabis Use and Psychosis Risk: A Systematic Review
por: van der Steur, Sanne J., et al.
Publicado: (2020)

T145. EFFECTS OF CANNABIDIOL ON EMOTION PROCESSING IN PSYCHOSIS RISK: AN FMRI INVESTIGATION
por: Davies, Cathy, et al.
Publicado: (2020)

17.3 EFFECT OF CANNABIDIOL ON SYMPTOMS, DISTRESS AND NEUROPHYSIOLOGICAL ABNORMALITIES IN CLINICAL HIGH-RISK FOR PSYCHOSIS PATIENTS: A PLACEBO-CONTROLLED STUDY
por: Bhattacharyya, Sagnik, et al.
Publicado: (2018)

Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis
por: Wilson, Robin, et al.
Publicado: (2019)

Therapeutic effect of psilocybin in addiction: A systematic review
por: van der Meer, Pim B., et al.
Publicado: (2023)

Cannabidiol as a potential treatment for psychosis
por: Davies, Cathy, et al.
Publicado: (2019)

A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis
por: Davies, Cathy, et al.
Publicado: (2020)

Who benefits most?
por: Van Diermen, L.
Publicado: (2021)

Acceptability of cannabidiol in patients with psychosis
por: Chesney, Edward, et al.
Publicado: (2022)

Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
por: Appiah-Kusi, E., et al.
Publicado: (2020)

T138. ADOLESCENT ONSET OF PSYCHOSIS IMPACTS SEGREGATION OF CORTICO-SUBCORTICAL NETWORKS DURING DEVELOPMENT
por: Ilzarbe, Daniel, et al.
Publicado: (2020)

Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence
por: Prud’homme, Mélissa, et al.
Publicado: (2015)

Cannabidiol modulation of hippocampal glutamate in early psychosis
por: O’Neill, Aisling, et al.
Publicado: (2021)

Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse
por: Sommer, Iris E, et al.
Publicado: (2022)

17.2 EFFICACY OF CANNABIDIOL IN THE TREATMENT OF EARLY PSYCHOSIS.
por: Ranganathan, Mohini, et al.
Publicado: (2018)

The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder
por: Garel, Nicolas, et al.
Publicado: (2021)

Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
por: Chesney, Edward, et al.
Publicado: (2021)

Cannabidiol and mental health: possibilities, uncertainties, and controversies for addiction treatment
por: Kessler, Felix H., et al.
Publicado: (2021)

Structural Brain Volumes of Individuals at Clinical High Risk for Psychosis: A Meta-analysis
por: Vissink, Conrad E., et al.
Publicado: (2021)

Association between gut permeability, brain volume, and cognition in healthy participants and patients with schizophrenia spectrum disorder
por: Scheurink, Toon Anton Willem, et al.
Publicado: (2023)

17. CANNABIDIOL AS A TREATMENT IN DIFFERENT STAGES OF PSYCHOSIS- EFFICACY AND MECHANISMS
por: Bhattacharyya, Sagnik
Publicado: (2018)

Who benefits most from Lyon’s bike sharing system?
por: Cambe, Jordan, et al.
Publicado: (2020)

A Process and Outcomes Evaluation of the International AIDS Conference: Who Attends? Who Benefits Most?
por: Lalonde, Bernadette, et al.
Publicado: (2007)

The antimicrobial potential of cannabidiol
por: Blaskovich, Mark A. T., et al.
Publicado: (2021)

Community Outreach for Navajo People Living with Diabetes: Who Benefits Most?
por: Trevisi, Letizia, et al.
Publicado: (2020)

Adjustable Versus Nonadjustable Sutures in Strabismus Surgery—Who Benefits the Most?
por: Gawęcki, Maciej
Publicado: (2020)

SilverCloud mental health feasibility study: who will it benefit the most?
por: Bartholmae, Marilyn M., et al.
Publicado: (2023)

Who benefits most from studying abroad? A conceptual and empirical overview
por: Netz, Nicolai
Publicado: (2021)

Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review
por: Furgiuele, Alessia, et al.
Publicado: (2021)

T174. STRUCTURAL ABNORMALITIES IN THE CINGULATE CORTEX IN ADOLESCENTS AT ULTRA-HIGH RISK WHO LATER DEVELOP PSYCHOSIS
por: Fortea, Adriana, et al.
Publicado: (2018)

Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment
por: Palumbo, Joseph M., et al.
Publicado: (2023)

Comorbid addictive behaviors in disordered gamblers with psychosis
por: Kim, Hyoun S., et al.
Publicado: (2018)

Who benefits most from early salvage radiation therapy after prostatectomy?
por: Nath, Sameer K., et al.
Publicado: (2018)

Among patients with advanced ovarian carcinoma, who benefits from bevacizumab the most?
por: Babaier, Abdulaziz, et al.
Publicado: (2023)

The therapeutic potential of purified cannabidiol
por: O’Sullivan, Saoirse Elizabeth, et al.
Publicado: (2023)

Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms
por: Casarett, David J., et al.
Publicado: (2019)

Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial
por: Aichholzer, Mareike, et al.
Publicado: (2022)

Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals
por: Galaj, Ewa, et al.
Publicado: (2020)

A serious game for children with Attention Deficit Hyperactivity Disorder: Who benefits the most?
por: Bul, Kim C. M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hunpnbcfteb25p7om9k4iua2i1